ProQR Therapeutics (PRQR) Other Operating Expenses (2014 - 2025)

ProQR Therapeutics (PRQR) posted Other Operating Expenses of -$0.0 for Q1 2025, up 87.5% sequentially from -$0.0 in Q4 2024.

ProQR Therapeutics (PRQR) Other Operating Expenses (2014 - 2025) Analysis & Trends

ProQR Therapeutics has reported Other Operating Expenses for 9 years, with the latest figure at -$0.0 in Q1 2025.

Quarterly Other Operating Expenses changed N/A year-over-year to -$0.0 in Q1 2025, while the trailing twelve-month figure through Dec 2025 was -$0.0 (up 88.89% YoY) and the FY2022 annual result came in at -$0.0, changed N/A from the prior year.
Other Operating Expenses improved to -$0.0 in Q1 2025 per PRQR's latest filing, from -$0.0 in the prior quarter.
Over five years, Other Operating Expenses peaked at $0.0 in Q4 2023 and troughed at -$0.0 in Q4 2024.
A 5-year average of -$0.0 and a median of -$0.0 in 2024 frame the typical range for Other Operating Expenses.
The sharpest annual moves came in 2022 and 2024: Other Operating Expenses plunged 300.0% in 2022, then plunged 200.0% in 2024.
Over 5 years, Other Operating Expenses stood at $0.0 in 2021, then surged by 100.0% to $0.0 in 2022, then jumped by 300.0% to $0.0 in 2023, then slumped by 200.0% to -$0.0 in 2024, then surged by 87.5% to -$0.0 in 2025.
According to Business Quant data, Other Operating Expenses over the past three periods registered -$0.0, -$0.0, and -$0.0 for Q1 2025, Q4 2024, and Q3 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	ProQR Therapeutics	206.80 Mn	111.86 Mn	-

Download Data